Morbidity of prostate cancer, kidney cancer, bladder cancer in Russia and Omsk region

Cover Page

Cite item

Full Text

Abstract

Comparative analysis of morbidity of prostate cancer, kidney cancer, bladder cancer in Russia and Omsk region for period since 1998 up to 2005 showed, that prostate adenocarcinoma is dominating among all urological cancers. Morbidity increase of prostate cancer for this period amounted to 103,6%. Kidney cancer took a second place (16%). Morbidity of bladder cancer reduced and (-6,2%) — negative dynamics was revealed. As a whole year-on-year increase of morbidity of cancer in Omsk region constituted 2,5%.

About the authors

O. V. Leonov

Omsk regional oncology dispensary

Author for correspondence.
Russian Federation

V. T. Dolgich

Omsk State Medical Academy

Russian Federation

E. I. Kopyltzov

Omsk regional oncology dispensary

Russian Federation

N. N. Golub

Omsk regional oncology dispensary

Russian Federation

V. M. Tomin

Omsk regional oncology dispensary

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36986 от  21.07.2009.